0001654954-26-003094
SEC filingFiscal 2025 was a challenging year for 374Water, marked by significant revenue decline and deepening losses as the company navigated execution delays and heavy investment in its AirSCWO technology commercialization, intensifying cash burn and liquidity pressure.
Revenue for fiscal 2025 was $215,037, a decrease of approximately 51.7% from the prior year. This decline is primarily attributable to a significant decrease in equipment revenue, which was partially offset by an increase in service revenues. The business context indicates that execution challenges, including equipment performance milestones, impacted revenue recognition. The company's revenue recognition for certain contracts is based on milestone completion against overall expected cost-plus margin estimates, and delays in meeting technical requirements, such as processing volume, directly constrained recognized revenue during the period.
Profitability eroded significantly, with gross profit at -$2,351,384 and an operating loss of -$21,147,064. The gross margin was deeply negative at -1093.5%, reflecting that cost of revenues substantially exceeded the low revenue base. The increase in operating loss was driven by heightened investment in the business. Management commentary notes a rise in stock-based compensation and recruiting fees associated with headcount increases in operations and board expansion, as the company built infrastructure for commercialization. These investments, while necessary for growth, significantly pressured near-term profitability.
The period was characterized by significant operational headwinds. The delay in equipment delivery and performance milestones, as referenced in the business context, illustrates the technical and execution challenges inherent in scaling the AirSCWO technology. Furthermore, the company experienced substantial management turnover, with the CEO, General Counsel, and CFO all replaced between October 2025 and March 2026. This instability contributed to the identification of a material weakness in internal control over financial reporting, attributed to insufficient, consistent finance department resources. While a remediation plan is underway, these control issues add operational and regulatory risk during a critical commercialization phase.
Looking forward, the company expects research and development expenses to increase as it continues to advance its technology. The need for additional capital is explicit, with management's commentary focusing on funding working capital and development. The asset recoverability assessment, comparing carrying amounts to future undiscounted cash flows, remains a relevant consideration for capital-intensive development projects. The company's ability to secure necessary funding, execute on its technical milestones, and manage its cost structure will be pivotal in navigating its path toward commercialization and achieving future financial sustainability.